Ken Suzuki

Professor Ken Suzuki is a clinical academic in cardiac surgery at Queen Mary University of London, affiliated with the William Harvey Research Institute within the Faculty of Medicine and Dentistry. He leads the Suzuki Lab, focusing on translational cardiovascular therapeutics. His research integrates stem cell therapy, gene therapy, and macrophage biology to address heart failure. He holds a PhD from Osaka University and has held roles at Imperial College London before joining Queen Mary in 2007.

Education:

• MD from Osaka University, Japan
• PhD in gene therapy for myocardial ischaemia-reperfusion injury

Research Interests:

• Stem cell delivery methods (e.g., epicardial placement)
• Role of tissue-repairing macrophages in heart failure
• iPSC-derived cardiomyocytes for myocardial regeneration
• Exosome-based therapies

Awards:

• Japan Society for the Promotion of Science Fellow
• UK Medical Research Council Senior Fellow

Advising & Grants:

• Supervises PhD/MRes students (e.g., Emrah Ozcan)
• Funded by the British Heart Foundation, Medical Research Council, and Barts Charity

Labs & Teams:

• Suzuki Lab (multi-disciplinary group)
• Advanced Bio-imaging Facility collaborations